Oreoch-1 cytotoxicity was tested using a (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)) assay on human colorectal adenocarcinoma (
Caco-2) cells, purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA). In detail, cells (3.5 × 10
4/well), routinely grown in Dulbecco’s Modified Eagle Medium (DMEM) and supplemented with 1% antibiotic solution, 1%
L-Glutamine, and 10%
Fetal Bovine Serum (FBS) (Microgem, Pozzuoli, Italy), were seeded in a 96-multiwell plate and incubated at 37 °C in a humified atmosphere with 5% CO
2. The following day, the adherent cell monolayer was treated with decreasing peptide concentrations (200–1.56 μM), and resuspended in water. The untreated cells and cells exposed to 100% dimethyl sulfoxide (DMSO) were considered as negative (CTR−) and positive (CTR+) controls, respectively. After 20 h (h) of treatment, the cell viability was determined using a 5 mg/mL
MTT solution (Sigma-Aldrich, St. Louis, MO, USA), by dispensing 100 μL in each well. After 3 h of incubation at 37 °C, the formazan crystals were dissolved with pure DMSO; then, the absorbance was read at 570 nm using a
microplate reader (Tecan, Männedorf, Switzerland). In the end, the percentage of cytotoxicity was calculated according to the following formula:
Palma F., Chianese A., Panico E., Greco G., Fusco A., Savio V., Ruocco E., Monti A., Doti N., Zannella C., Donnarumma G., De Filippis A, & Galdiero M. (2023). Oreoch-1: A Peptide from Oreochromis niloticus as a Potential Tool against Staphylococci. Pathogens, 12(10), 1188.